Trial intelligence / Profile preview

PEDOCELL cellulitis antibiotic non-inferiority trial

2016-001528-69Phase 4Terminated

Sponsor
RCSI University of Medicine and Health Sciences
Start
Aug 2016
Modality
Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in cellulitis, Not applicable, Wound infection (WI) and 1 more comparing Flucloxacillin monotherapy with Flucloxacillin plus phenoxymethylpenicillin (2 arms). Primary endpoint: Clinical cure at test-of-cure visit. Started Aug 2016; status: terminated.

02

Drugs

flucloxacillinphenoxymethylpenicillin
03

Conditions

cellulitisNot applicableWound infection (WI)abscess

Beyond the preview

Go deeper on 2016-001528-69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001528-69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call